Shahd H. Shaar
Hamad Medical Corporation(QA)
Publications by Year
Research Areas
COVID-19 Clinical Research Studies, Long-Term Effects of COVID-19, SARS-CoV-2 and COVID-19 Research, Antibiotic Use and Resistance, COVID-19 and healthcare impacts
Most-Cited Works
- → Stigma associated with mental illness and its treatment in the Arab culture: A systematic review(2018)277 cited
- → Tocilizumab for the treatment of severe coronavirus disease 2019(2020)268 cited
- → The first consecutive 5000 patients with Coronavirus Disease 2019 from Qatar; a nation-wide cohort study(2020)55 cited
- → Switch to oral antibiotics in Gram-negative bacteraemia: a randomized, open-label, clinical trial(2023)26 cited
- → The First Consecutive 5000 Patients with COVID-19 in Qatar; a Nation-wide Cohort Study(2020)9 cited
- → Assessing the evidence based medicine educational needs of community pharmacy preceptors within an experiential program in Qatar(2017)9 cited
- → Coronavirus disease 2019 in solid organ transplant recipients in the setting of proactive screening and contact tracing of Qatar(2021)2 cited
- → Practice patterns of antiphospholipid syndrome at a tertiary teaching hospital in Lebanon(2002)2 cited
- → Coronavirus disease 2019 in solid organ transplant recipients in a setting of proactive screening and contact tracing(2021)1 cited
- → Favipiravir for the treatment of coronavirus disease 2019 pneumonia; a propensity score-matched cohort study(2022)